Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Ehlermann

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
United European Gastroenterology Journal|June 19, 2019
The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent <i>Clostridioides difficile</i> infections in GermanyRosemarie Peri, Rebeca Cruz Aguilar, Kester Tüffers, et al.
The Journal of Biological Chemistry|June 5, 2003
Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performancePatrick Most, Andrew Remppis, Sven T Pleger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 16, 2012
Green tea halts progression of cardiac transthyretin amyloidosis: an observational reportArnt V Kristen, Stephanie Lehrke, Sebastian Buss, et al.
Nature Medicine|November 3, 2009
Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathyDavid Hassel, Tillman Dahme, Jeanette Erdmann, et al.
European Heart Journal|September 23, 2017
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker-Kleiner, Arash Haghikia, Dominik Berliner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 20, 2018
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunctionArash Haghikia, Johannes Schwab, Jens Vogel-Claussen, et al.
Circulation. Heart Failure|January 12, 2018
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled StudyIacopo Olivotto, Paolo G Camici, Piera Angelica Merlini, et al.
Deutsches Arzteblatt International|September 24, 2016
Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile InfectionStefan Hagel, Anne Fischer, Philipp Ehlermann, et al.
EMBO Molecular Medicine|January 24, 2013
Alterations in cardiac DNA methylation in human dilated cardiomyopathyJan Haas, Karen S Frese, Yoon Jung Park, et al.
European Heart Journal|October 14, 2017
Clinical genetics and outcome of left ventricular non-compaction cardiomyopathyFarbod Sedaghat-Hamedani, Jan Haas, Feng Zhu, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
United European Gastroenterology Journal|June 19, 2019
The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent <i>Clostridioides difficile</i> infections in GermanyRosemarie Peri, Rebeca Cruz Aguilar, Kester Tüffers, et al.
The Journal of Biological Chemistry|June 5, 2003
Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performancePatrick Most, Andrew Remppis, Sven T Pleger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 16, 2012
Green tea halts progression of cardiac transthyretin amyloidosis: an observational reportArnt V Kristen, Stephanie Lehrke, Sebastian Buss, et al.
Nature Medicine|November 3, 2009
Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathyDavid Hassel, Tillman Dahme, Jeanette Erdmann, et al.
European Heart Journal|September 23, 2017
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker-Kleiner, Arash Haghikia, Dominik Berliner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 20, 2018
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunctionArash Haghikia, Johannes Schwab, Jens Vogel-Claussen, et al.
Circulation. Heart Failure|January 12, 2018
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled StudyIacopo Olivotto, Paolo G Camici, Piera Angelica Merlini, et al.
Deutsches Arzteblatt International|September 24, 2016
Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile InfectionStefan Hagel, Anne Fischer, Philipp Ehlermann, et al.
EMBO Molecular Medicine|January 24, 2013
Alterations in cardiac DNA methylation in human dilated cardiomyopathyJan Haas, Karen S Frese, Yoon Jung Park, et al.
European Heart Journal|October 14, 2017
Clinical genetics and outcome of left ventricular non-compaction cardiomyopathyFarbod Sedaghat-Hamedani, Jan Haas, Feng Zhu, et al.
Pageof 9